Related Experiment Video
Updated: Jul 2, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
Unveiling the role of ZIKV NS4A mutants F4L and E8D through molecular docking and dynamics simulation: implications
Afshan Salam1, Usama Ilahi1, Mian Hazrat Yousuf2
1Center for Biotechnology and Microbiology, University of Swat, Swat, Pakistan.
Abstract:
Zika virus (ZIKV), a mosquito-borne flavivirus, has emerged as a global health concern due to its association with congenital microcephaly and neurological disorders. The non-structural protein NS4A plays a pivotal role in viral replication and immune evasion by antagonizing the mitochondrial antiviral signaling protein (MAVS). In this study, we evaluated four NS4A mutations (L48M, K42E, F4L, and E8D). Only F4L and E8D showed destabilizing effects and were selected for further analysis. We used molecular docking, 300 ns molecular dynamics simulations, and binding free energy calculations to assess their effects on NS4A-MAVS binding. Stability investigations root means square deviation (RMSD) root mean square fluctuation (RMSF) and radius of gyration (Rg) revealed that both mutations changed the conformational dynamics of NS4A-MAVS complexes, with F4L displaying transitory fluctuations and E8D exhibiting long-term structural flexibility. Hydrogen bond research revealed that both mutants had stronger interaction networks with MAVS compared to the natural type. MM/PBSA computations showed that F4L and E8D had reduce binding affinities, with ΔG values of - 54.05 kcal/mol and - 56.25 kcal/mol, respectively, compared to - 61.73 kcal/mol in the wild type. The stronger electrostatic contributions observed in the E8D complex highlight its potential to further disrupt MAVS-mediated interferon induction. Collectively, these results suggest that the F4L and particularly E8D mutations enhance the immune-evasive capacity of ZIKV by stabilizing NS4A-MAVS interactions, offering insights into viral pathogenesis and providing a computational basis for therapeutic targeting of NS4A.
Supplementary Information:
The online version contains supplementary material available at 10.1007/s40203-025-00540-0.
Insights
Zika virus (ZIKV) mutations F4L and E8D in the NS4A protein were found to enhance viral immune evasion. These mutations stabilize interactions with MAVS, potentially disrupting interferon induction and aiding ZIKV pathogenesis.
Area of Science:
- Virology and Molecular Biology
- Immunology
- Computational Biology
Background:
- Zika virus (ZIKV) poses a global health threat, linked to microcephaly and neurological issues.
- The ZIKV non-structural protein NS4A is crucial for viral replication and immune evasion by inhibiting MAVS.
- Understanding NS4A-MAVS interactions is key to ZIKV pathogenesis and therapeutic strategies.
Purpose of the Study:
- To investigate the impact of specific NS4A mutations (F4L, E8D) on ZIKV's interaction with MAVS.
- To assess how these mutations affect viral immune evasion mechanisms.
- To provide a computational basis for targeting ZIKV NS4A.
Main Methods:
- Molecular docking and 300 ns molecular dynamics simulations were employed.
- Binding free energy calculations (MM/PBSA) were used to quantify interaction strengths.
- Analysis of structural dynamics (RMSD, RMSF, Rg) and hydrogen bonding patterns was performed.
Main Results:
- F4L and E8D mutations altered the conformational dynamics of NS4A-MAVS complexes.
- Both mutants exhibited enhanced interaction networks with MAVS compared to the wild type.
- F4L and E8D showed reduced binding affinities, with E8D demonstrating significant electrostatic contributions potentially disrupting interferon induction.
Conclusions:
- The F4L and E8D mutations in ZIKV NS4A enhance immune evasion by stabilizing NS4A-MAVS interactions.
- The E8D mutation, in particular, shows potential for disrupting MAVS-mediated interferon signaling.
- These findings offer insights into ZIKV pathogenesis and suggest NS4A as a therapeutic target.
Related Concept Videos
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly

